The image of the leadless AVEIR DR pacemaker. CTV News
Just two weeks after getting a new pacemaker in May, 77-year-old John Kebert was back on his beloved hikes, enjoying the outdoors once again. John is one of the first 15 patients in Calgary to receive a groundbreaking device known as the AVEIR DR pacemaker at Foothills Medical Centre (FMC).
Unlike traditional pacemakers, which are bulky and require major chest surgery, the AVEIR DR is much smaller—about one-tenth the size of its predecessors. It’s inserted through a small incision in the leg, making the procedure less invasive and significantly easier on patients. This new pacemaker is currently available only at FMC and the Montreal Heart Institute in Canada.
The AVEIR DR offers a shorter recovery time compared to older models. Patients can usually return to their normal activities within days, rather than the several weeks or even months required with traditional devices. John Kebert noticed this improvement firsthand. He shared that, before the procedure, hiking up mountains was challenging and left him breathless. However, since receiving the dual-chamber device, he feels much better and is enjoying his hikes again.
Dr. Derek Exner, a heart rhythm specialist at FMC, explained the benefits of the AVEIR DR. This new device helps replace the heart's electrical system for those who experience a slow heartbeat or related issues. It not only addresses these problems but also reduces the risk of complications and infections that can come with traditional pacemakers.
John Kebert, 77, from Alberta, has received the new leadless AVEIR DR pacemaker. Standing beside him is Dr. Derek Exner, a heart rhythm specialist from Foothills Medical Centre. CTV News
The AVEIR DR pacemaker has a battery life of around ten years and is leadless, meaning it doesn’t have the wires that traditional pacemakers use. The implantation process is quick and minimally invasive, allowing patients like John to often leave the hospital on the same day as the procedure.
Dr. Exner noted that with older pacemakers, patients are advised to limit their movements and avoid certain activities like swimming for up to a month. In contrast, those with the new device can resume their regular activities much sooner. Some are even engaging in vigorous activities within a week or two.
At present, the AVEIR DR pacemaker is primarily available to individuals participating in research studies or those at high risk of infection. It is also more expensive than traditional pacemakers. However, there is a strong interest in expanding access to this advanced device beyond Calgary and Montreal.
Dr. Exner expressed hope that more cities across Canada and around the world will soon offer the AVEIR DR pacemaker, noting that the demand is high and many people are eager to benefit from this new technology.
